The Financial Burden of Post-Treatment Care for Cancer Survivors

Nearly 19 million Americans are living as cancer survivors, according to recent data, yet many continue to face significant financial strain long after completing active treatment. Ongoing costs for follow-up monitoring, prescription medications and managing treatment side effects often force difficult choices about healthcare access. This article examines the realities of post-treatment financial burdens, explores current policy proposals aimed at reducing insurance costs, and evaluates their potential impact on this growing population.

The Ongoing Cost of Survivorship

Completing cancer treatment does not mark the end of medical expenses for many patients. Survivors frequently require regular check-ups, imaging scans, blood tests, and specialist visits to monitor for recurrence and manage long-term side effects of chemotherapy, radiation, or surgery. These follow-up care needs can persist for years or even a lifetime, depending on the cancer type and individual risk factors.

Out-of-pocket costs—including deductibles, copayments, and coinsurance—can accumulate rapidly, particularly for those without comprehensive insurance coverage. A 2026 KFF Health News report highlighted the experience of Marielle Santos McLeod, a 45-year-old colon cancer survivor from South Carolina, who reported spending $2,500 in the first two months of the year on post-treatment care and owing an additional $1,300 from a January colonoscopy. These expenses were in addition to her $895 monthly health insurance premium for a family plan.

Such financial pressures have led some survivors to delay or forgo necessary care. McLeod, for example, described putting off a CT scan and cardiology consultation despite experiencing intense chest pain, stating she was “forced to pick and choose as to where your priorities really need to be.” This practice of rationing care due to cost is not uncommon among cancer survivors navigating the healthcare system post-treatment.

Current Policy Proposals and Their Limitations

In recent years, certain policymakers have promoted high-deductible health plans (HDHPs) paired with health savings accounts (HSAs) as a strategy to lower insurance premiums and increase consumer control over healthcare spending. Proponents argue that these plans encourage cost-conscious decision-making and reduce overall expenditures.

However, health policy researchers and patient advocates have expressed concern that such approaches may not adequately protect individuals with chronic or high-cost medical needs—including cancer survivors. High deductibles require patients to pay substantial amounts out of pocket before insurance coverage begins, which can be prohibitive for those needing frequent follow-up care, imaging, or specialty consultations.

The same KFF Health News article noted that experiences like McLeod’s “reveal the limits of the Trump administration’s proposals to lower premiums, which may not support” patients facing persistent medical expenses. Similarly, a separate report from WGBH News explained that while HDHPs have become more common over the past two decades, many Republicans in Congress remain reluctant to extend government subsidies under the Affordable Care Act that help offset premiums and out-of-pocket costs for lower- and middle-income individuals.

Critics argue that shifting more financial responsibility onto patients through HDHPs and HSAs may exacerbate inequities in access to necessary survivorship care, particularly for those without sufficient savings to cover high deductibles or those managing complex, long-term health needs.

Who Is Affected?

Cancer survivorship is increasingly common due to advances in early detection and treatment. As of 2026, the National Cancer Institute estimates that nearly 19 million people in the United States have a history of cancer—a number projected to grow in the coming years. While survival rates have improved for many cancer types, the journey often involves ongoing medical surveillance and management of late effects such as cardiovascular disease, secondary cancers, infertility, or cognitive changes.

These long-term needs translate into sustained healthcare utilization and associated costs. Survivors may require:

• Regular oncology follow-up visits (typically every 3–6 months for several years)
• Periodic imaging (e.g., mammograms, colonoscopies, CT scans)
• Blood tests to monitor organ function or tumor markers
• Care from specialists such as cardiologists, pulmonologists, or endocrinologists
• Prescription medications for pain, hormone therapy, or mental health support
• Rehabilitation services (e.g., physical therapy, lymphedema management)

Each of these services carries potential out-of-pocket costs, especially under insurance plans with high deductibles or limited provider networks.

Key Takeaways

• Millions of cancer survivors in the U.S. Continue to face significant out-of-pocket costs for follow-up care and monitoring long after active treatment ends.
• Financial strain can lead some survivors to delay or avoid necessary medical care, despite experiencing symptoms that warrant evaluation.
• Policy proposals focused on lowering premiums through high-deductible plans and health savings accounts may not adequately address the needs of individuals with ongoing, high-utilization healthcare needs.
• Experts emphasize that sustainable solutions must balance cost containment with protections for patients requiring frequent or expensive follow-up services.
• As the population of cancer survivors grows, addressing the financial toxicity of survivorship remains a critical public health challenge.

Frequently Asked Questions

What is “financial toxicity” in cancer care?

Financial toxicity refers to the financial burden and distress experienced by patients due to the cost of cancer treatment and care. It can include debt, bankruptcy, income loss, and the psychological stress of managing medical expenses. For survivors, financial toxicity often persists during the post-treatment phase due to ongoing surveillance and symptom management needs.

Do all cancer survivors need long-term follow-up care?

The need for follow-up care varies by cancer type, stage at diagnosis, treatments received, and individual risk factors. Some survivors require only periodic check-ups for a few years, while others—such as those treated for certain breast, colon, or hematologic cancers—may need lifelong monitoring for recurrence or late effects.

Are there programs to help cancer survivors with medical costs?

Yes, several nonprofit organizations and hospital-based programs offer financial assistance, case management, and resources to help survivors navigate insurance, access affordable care, and manage out-of-pocket costs. Examples include the Cancer Hope Network, Patient Advocate Foundation, and various cancer-specific support groups. However, availability and eligibility vary by location and circumstance.

How do high-deductible health plans affect cancer survivors?

Under an HDHP, survivors must pay all covered services out of pocket until they meet their annual deductible—which can be thousands of dollars—before insurance begins to share costs. For those needing frequent doctor visits, scans, or medications, this can result in high upfront expenses each year, potentially discouraging timely care.